LXEO
Lexeo Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.55 / 10
Outperform
Money flow analysis registers 7.61/10, showing robust fund flow characteristics. Positive momentum in overall, block, Small, Medium, and Extra-large is countered by negative tendencies in Large, suggesting positive flow conditions. Analyst sentiment reflects overwhelmingly bullish analyst consensus with strong conviction. The rating profile includes Strong Buy(100.0%) from 2 analytical reports, supported by 7.49 historical weighted rating.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-13
InstitutionChardan Capital
Times predicted8
Historical Win Rate75.0%
Is money flowing into or out of LXEO?
- LXEO holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.55/10 (Outperform).
